Literature DB >> 16263849

The capacity to vote of persons with Alzheimer's disease.

Paul S Appelbaum1, Richard J Bonnie, Jason H Karlawish.   

Abstract

OBJECTIVE: The right to vote can be abrogated when persons become incompetent to cast a ballot. This applies particularly to people with Alzheimer's disease, who at some point will lose capacity. A 2001 federal court decision offered the first clear criteria ("Doe voting capacity standard") for determining voting competence, focused on understanding the nature and effect of voting and on the ability to choose. This article explores how persons with Alzheimer's disease perform on these criteria.
METHOD: The Doe standard was operationalized in a brief questionnaire, along with measures of appreciation and reasoning about voting choices. Performance was assessed in 33 patients attending an Alzheimer's disease clinic and was related to dementia severity and demographic characteristics.
RESULTS: The interview questions were scored with high reliability. Performance on the Doe questions, along with appreciation and reasoning, correlated strongly with Mini-Mental State Examination (MMSE) scores. Patients with very mild to mild Alzheimer's disease generally retained adequate ability to vote, and most persons with severe Alzheimer's disease did not. Performance was highly variable among persons with moderate Alzheimer's disease. The desire to vote was a poor predictor of voting capacity.
CONCLUSIONS: The capacity to vote, as embodied in the Doe voting capacity standard, can be measured simply and reliably. Structured assessment is particularly likely to be useful for people with moderate Alzheimer's disease, whose performance cannot be predicted from MMSE scores alone. This approach can ensure retention of voting rights by capable persons and exclusion of clearly impaired persons from the voting booth.

Entities:  

Mesh:

Year:  2005        PMID: 16263849     DOI: 10.1176/appi.ajp.162.11.2094

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

1.  Correlates of functional dependence among recently admitted assisted living residents with and without dementia.

Authors:  Quincy M Samus; Lawrence Mayer; Chiadi U Onyike; Jason Brandt; Alva Baker; Matthew McNabney; Peter V Rabins; Constantine G Lyketsos; Adam Rosenblatt
Journal:  J Am Med Dir Assoc       Date:  2009-06       Impact factor: 4.669

Review 2.  Consent in impaired populations.

Authors:  Paul S Appelbaum
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

Review 3.  Dementia, Decision Making, and Capacity.

Authors:  R Ryan Darby; Bradford C Dickerson
Journal:  Harv Rev Psychiatry       Date:  2017 Nov/Dec       Impact factor: 3.732

Review 4.  Measuring decision-making capacity in cognitively impaired individuals.

Authors:  Jason Karlawish
Journal:  Neurosignals       Date:  2007-12-05

5.  Evaluating voting competence in persons with Alzheimer disease.

Authors:  Pietro Tiraboschi; Erica Chitò; Leonardo Sacco; Marta Sala; Stefano Stefanini; Carlo Alberto Defanti
Journal:  Int J Alzheimers Dis       Date:  2011-07-14

6.  Capacity to vote in persons with dementia and the elderly.

Authors:  Luis Javier Irastorza; Pablo Corujo; Pilar Bañuelos
Journal:  Int J Alzheimers Dis       Date:  2011-07-18

7.  An assessment of voting knowledge and related decisions amongst hospitalised mental healthcare users in South Africa.

Authors:  Felicity Marcus; Yvette Nel
Journal:  S Afr J Psychiatr       Date:  2021-01-29       Impact factor: 1.550

8.  Protected adults' voting rights: an interdisciplinary study of medical assessment and jurisprudence in France.

Authors:  Antoine Bosquet; Isabelle Mahé
Journal:  BMJ Open       Date:  2018-07-23       Impact factor: 2.692

Review 9.  What are the boundaries of legal guardianship in Alzheimer's disease? An evidence-based update in the context of the Brazilian Civil Code.

Authors:  Felipe K Sudo; Ana C Salles; Clarisse R de Santiago
Journal:  Braz J Psychiatry       Date:  2016-03       Impact factor: 2.697

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.